Mary Crowley Cancer Research /ID# 210716 — Dallas, Texas

Mary Crowley Cancer Research /ID# 210716 is a clinical research site located in Dallas, Texas, United States 75230.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Mary Crowley Cancer Research /ID# 210716 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Cancer, Advanced Solid Tumors, Triple-Negative Breast Cancer (TNBC).

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mary Crowley Cancer Research /ID# 210716?

Mary Crowley Cancer Research /ID# 210716 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mary Crowley Cancer Research /ID# 210716 conducted?

Mary Crowley Cancer Research /ID# 210716 has 1 clinical trials on record, with 1 currently active. Their work covers Cancer, Advanced Solid Tumors, Triple-Negative Breast Cancer (TNBC).

Is Mary Crowley Cancer Research /ID# 210716 accredited by Crixeo Health?

Mary Crowley Cancer Research /ID# 210716 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mary Crowley Cancer Research /ID# 210716?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.